[1]
Chovatiya, R., Wollenberg, A. , Ribero, S., Saeki, H., Øland, C., Steffensen, L., Tindberg, A.-M., Thyssen, J. and Blauvelt, A. 2024. Improvement of the Head and Neck Regions with Continuous Tralokinumab treatment for Up to 4 years in Adults with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s316. DOI:https://doi.org/10.25251/skin.8.supp.316.